Violich Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,125
| Closed | -$185K | – | 119 |
|
|
2017
Q3 | $185K | Hold |
11,125
| – | – | 0.05% | 109 |
|
|
2017
Q2 | $199K | Hold |
11,125
| – | – | 0.06% | 103 |
|
|
2017
Q1 | $223K | Hold |
11,125
| – | – | 0.07% | 100 |
|
|
2016
Q4 | $288K | Hold |
11,125
| – | – | 0.09% | 87 |
|
|
2016
Q3 | $260K | Hold |
11,125
| – | – | 0.09% | 82 |
|
|
2016
Q2 | $222K | Hold |
11,125
| – | – | 0.07% | 87 |
|
|
2016
Q1 | $188K | Buy |
11,125
+1,875
| +20% | +$38.4K | 0.06% | 91 |
|
|
2015
Q4 | $205K | Sell |
9,250
-1,500
| -14% | -$31.2K | 0.07% | 88 |
|
|
2015
Q3 | $182K | Hold |
10,750
| – | – | 0.06% | 89 |
|
|
2015
Q2 | $148K | Hold |
10,750
| – | – | 0.05% | 94 |
|
|
2015
Q1 | $147K | Hold |
10,750
| – | – | 0.05% | 95 |
|
|
2014
Q4 | $114K | Hold |
10,750
| – | – | 0.04% | 95 |
|
|
2014
Q3 | $134K | Sell |
10,750
-795
| -7% | -$11.1K | 0.04% | 97 |
|
|
2014
Q2 | $158K | Sell |
11,545
-1,475
| -11% | -$19.3K | 0.05% | 99 |
|
|
2014
Q1 | $157K | Hold |
13,020
| – | – | 0.05% | 97 |
|
|
2013
Q4 | $160K | Sell |
13,020
-2,900
| -18% | -$34K | 0.06% | 95 |
|
|
2013
Q3 | $162K | Sell |
15,920
-940
| -6% | -$8.79K | 0.06% | 101 |
|
|
2013
Q2 | $151K | Buy |
+16,860
| New | +$170K | 0.06% | 99 |
|
Violich Capital Management's OME Position: Q4 2017 in Review
Violich Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 11,125 shares — an estimated $185K sold.
Violich Capital Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $288K in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Violich Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Violich Capital Management sold 11,125 Omega Protein shares in Q4 2017, an estimated $185K.
- Violich Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Violich Capital Management's Omega Protein position peaked at $288K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Violich Capital Management's 13F filing for Q4 2017, filed 1 Mar 2018.